Message #9 From:
NewsBot Date: December 1, 2006 01:21:00 PM
ADLI News American Medical Technologies Reports Strong Third Quarter Results
CORPUS CHRISTI, Texas--(BUSINESS WIRE)--American Medical Technologies, Inc. (OTCBB:ADLI) reported its financial
results for the three and nine months ended September 30, 2006. Those
results, compared with results for the same periods in 2005, are as
follows:
Third-quarter revenues rose sharply, up 51% from a year ago.
Net loss per share was cut in half, $0.02 per share for the third
quarter of 2006, compared with a $0.04 per share loss for the third
quarter last year.
Nine month revenues rose 15% over last year.
American Medical Technologies reported that revenues for the third
quarter 2006 were $768,686, compared to $510,564 for the third quarter
2005.
The increase in quarterly revenues included stronger sales of the company’s
products boosted by domestic and international marketing efforts led by
Judd Hoffman, Vice President of Worldwide Sales. In addition, the
company experienced favorable results from sales of Spectrum Dental
whitening products. In April 2006, American Medical Technologies, Inc.
entered into a 5 year exclusive distribution agreement of the Spectrum
Dental product line.
Third-quarter net loss was $176,343, or $0.02 per share, compared to a
net loss of $320,217 or $0.04 per share for the third quarter of 2005.
Higher revenues and continued efforts to remain an efficient operation
contributed to lower losses in the quarter.
For the first nine months of 2006, revenues were $1.85 million, versus
$1.60 million for the first nine months of 2005. Net loss for the first
nine months was $1.39 million, or $0.17 per share, compared with a net
loss of $874,286, or $0.11 per share in 2005. The increase was primarily
due to a one-time $410,000 settlement, or $0.05 per share and increased
marketing costs.
“The third quarter results demonstrate the
success of our marketing program which is just starting to take effect.
We believe our dental products provide dentists with the next generation
in the growing whitening market, while our patented hydrobrasion dental
equipment offers improved patient comfort and greater speed for many
common procedures, compared with traditional handpiece drills,”
said Roger Dartt, President and Chief Executive Officer of American
Medical Technologies. “We are very excited
going forward as we initiate our marketing program. We are already
seeing strong results, and have plans to bring additional sales force on
board and grow our outside distribution network which should add to the
strong sales momentum we saw in the third quarter.
AMT, headquartered in Corpus Christi, Texas, develops and manufactures
advanced technologies in the field of dentistry and markets them
worldwide. The company’s securities are quoted
on the OTC Bulletin Board under the symbol ADLI, and its website is at www.americanmedicaltech.com.
The Company makes forward-looking statements in this press release and
in its filings with the Securities and Exchange Commission. The Company’s
forward-looking statements are subject to risks and uncertainties and
include information about its expectations and possible or assumed
future results of operations. When the Company uses any of the words “believes”,
“expects”, “anticipates”,
“estimates” or
similar expressions, it is making forward-looking statements.
The Company claims the protection of the safe harbor for forward-looking
statements contained in the Private Securities Litigation Reform Act of
1995 for all of its forward-looking statements. While the Company
believes that its forward-looking statements are reasonable, you should
not place undue reliance on any such forward-looking statements, which
speak only as of the date made. Because these forward-looking statements
are based on estimates and assumptions that are subject to significant
business, economic and competitive uncertainties, many of which are
beyond the Company’s control or are subject
to change, actual results could be materially different. Factors that
might cause such a difference include, without limitation, the
following: the Company’s inability to
generate sufficient cash flow to meet its current liabilities, the
Company’s potential inability to hire and
retain qualified sales and service personnel, the potential for an
extended decline in sales, the possible failure of revenues to offset
additional costs associated with its change in business model, the
potential lack of product acceptance, the Company’s
potential inability to introduce new products to the market, the
potential failure of customers to meet purchase commitments, the
potential loss of customer relationships, the potential failure to
receive or maintain necessary regulatory approvals, the extent to which
competition may negatively affect prices and sales volumes or
necessitate increased sales expenses, and the other risks and
uncertainties set forth in this report.
Other factors not currently anticipated by management may also
materially and adversely affect the Company’s
results of operations. Except as required by applicable law, the Company
does not undertake any obligation to publicly release any revisions
which may be made to any forward-looking statements to reflect events or
circumstances occurring after the date of this report.
American Medical Technologies, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
Three Months Ended September 30
Nine Months Ended September 30
2006
2005
2006
2005
Revenues
$
768,686
$
510,564
$
1,846,797
$
1,601,879
Royalties
7,307
3,958
23,716
90,716
775,993
514,522
1,870,513
1,692,595
Cost of sales
371,959
353,237
1,031,523
896,080
Gross profit
404,034
161,285
838,990
796,515
Selling, general and administrative
614,170
488,061
2,207,085
1,635,356
Research and development
16,617
54,389
55,470
131,248
Loss from operations
(226,752)
(381,165)
(1,423,565)
(970,089)
Other income (expenses)
Net realized and unrealized gains/(loss) on investments